Manu S Goyal1, Brian G Hoff1, Jennifer Williams1, Naim Khoury1, Rebecca Wiesehan1, Laura Heitsch1, Peter Panagos1, Katie D Vo1, Tammie Benzinger1, Colin P Derdeyn1, Jin-Moo Lee1, Andria L Ford2. 1. From the Mallinckrodt Institute of Radiology (M.S.G., K.D.V., T.B., C.P.D., J.-M.L.), Department of Neurology (R.W., C.P.D., J.-M.L., A.L.F.), Division of Emergency Medicine (L.H., P.P.), and Department of Neurological Surgery (C.P.D.), Washington University School of Medicine, St Louis, MO; Department of Operational Excellence (B.G.H.) and Department of Emergency Services (J.W.), Barnes-Jewish Hospital, St Louis, MO; Department of Neuroradiology, University of Montreal, Montreal, Quebec, Canada (N.K.); and Department of Biomedical Engineering, Washington University, St Louis, MO (J.-M.L.). 2. From the Mallinckrodt Institute of Radiology (M.S.G., K.D.V., T.B., C.P.D., J.-M.L.), Department of Neurology (R.W., C.P.D., J.-M.L., A.L.F.), Division of Emergency Medicine (L.H., P.P.), and Department of Neurological Surgery (C.P.D.), Washington University School of Medicine, St Louis, MO; Department of Operational Excellence (B.G.H.) and Department of Emergency Services (J.W.), Barnes-Jewish Hospital, St Louis, MO; Department of Neuroradiology, University of Montreal, Montreal, Quebec, Canada (N.K.); and Department of Biomedical Engineering, Washington University, St Louis, MO (J.-M.L.). forda@neuro.wustl.edu.
Abstract
BACKGROUND AND PURPOSE: Stroke mimics (SM) challenge the initial assessment of patients presenting with possible acute ischemic stroke (AIS). When SM is considered likely, intravenous tissue-type plasminogen activator (tPA) may be withheld, risking an opportunity to treat AIS. Although computed tomography is routinely used for tPA decision making, magnetic resonance imaging (MRI) may diagnose AIS when SM is favored but not certain. We hypothesized that a hyperacute MRI (hMRI) protocol would identify tPA-eligible AIS patients among those initially favored to have SM. METHODS: A streamlined hMRI protocol was designed based on barriers to rapid patient transport, MRI acquisition, and post-MRI tPA delivery. Neurologists were trained to order hMRI when SM was favored and tPA was being withheld. The use of hMRI for tPA decision making, door-to-needle times, and outcomes were compared before hMRI implementation (pre-hMRI: August 1, 2011 to July 31, 2013) and after (post-hMRI, August 1, 2013, to January 15, 2015). RESULTS: Post hMRI, 57 patients with suspected SM underwent hMRI (median MRI-order-to-start time, 29 minutes), of whom, 11 (19%) were diagnosed with AIS and 7 (12%) received tPA. Pre-hMRI, no tPA-treated patients were screened with hMRI. Post hMRI, 7 of 106 (6.6%) tPA-treated patients underwent hMRI to aid in decision making because of suspected SM (0% versus 6.6%; P=0.001). To ensure standard care was maintained after implementing the hMRI protocol, pre- versus post-hMRI tPA-treated cohorts were compared and did not differ: door-to-needle time (39 versus 37 minutes; P=0.63), symptomatic hemorrhage rate (4.5% versus 1.9%; P=0.32), and favorable discharge location (85% versus 89%; P=0.37). CONCLUSIONS: A streamlined hMRI protocol permitted tPA administration to a small, but significant, subset of AIS patients initially considered to have SM.
BACKGROUND AND PURPOSE:Stroke mimics (SM) challenge the initial assessment of patients presenting with possible acute ischemic stroke (AIS). When SM is considered likely, intravenous tissue-type plasminogen activator (tPA) may be withheld, risking an opportunity to treat AIS. Although computed tomography is routinely used for tPA decision making, magnetic resonance imaging (MRI) may diagnose AIS when SM is favored but not certain. We hypothesized that a hyperacute MRI (hMRI) protocol would identify tPA-eligible AISpatients among those initially favored to have SM. METHODS: A streamlined hMRI protocol was designed based on barriers to rapid patient transport, MRI acquisition, and post-MRI tPA delivery. Neurologists were trained to order hMRI when SM was favored and tPA was being withheld. The use of hMRI for tPA decision making, door-to-needle times, and outcomes were compared before hMRI implementation (pre-hMRI: August 1, 2011 to July 31, 2013) and after (post-hMRI, August 1, 2013, to January 15, 2015). RESULTS: Post hMRI, 57 patients with suspected SM underwent hMRI (median MRI-order-to-start time, 29 minutes), of whom, 11 (19%) were diagnosed with AIS and 7 (12%) received tPA. Pre-hMRI, no tPA-treated patients were screened with hMRI. Post hMRI, 7 of 106 (6.6%) tPA-treated patients underwent hMRI to aid in decision making because of suspected SM (0% versus 6.6%; P=0.001). To ensure standard care was maintained after implementing the hMRI protocol, pre- versus post-hMRItPA-treated cohorts were compared and did not differ: door-to-needle time (39 versus 37 minutes; P=0.63), symptomatic hemorrhage rate (4.5% versus 1.9%; P=0.32), and favorable discharge location (85% versus 89%; P=0.37). CONCLUSIONS: A streamlined hMRI protocol permitted tPA administration to a small, but significant, subset of AISpatients initially considered to have SM.
Authors: Shreyansh Shah; Marie Luby; Karen Poole; Teresa Morella; Elizabeth Keller; Richard T Benson; John K Lynch; Zurab Nadareishvili; Amie W Hsia Journal: Neurology Date: 2015-05-13 Impact factor: 9.910
Authors: Ronen R Leker; Galina Keigler; Roni Eichel; Tamir Ben Hur; John M Gomori; Jose E Cohen Journal: Int J Stroke Date: 2014-08 Impact factor: 5.266
Authors: Sanne M Zinkstok; Stefan T Engelter; Henrik Gensicke; Philippe A Lyrer; Peter A Ringleb; Ville Artto; Jukka Putaala; Elena Haapaniemi; Turgut Tatlisumak; Yaohua Chen; Didier Leys; Hakan Sarikaya; P Michel; Céline Odier; Jörg Berrouschot; Marcel Arnold; Mirjam R Heldner; Andrea Zini; Valentina Fioravanti; Visnja Padjen; Ljiljana Beslac-Bumbasirevic; Alessandro Pezzini; Yvo B Roos; Paul J Nederkoorn Journal: Stroke Date: 2013-02-26 Impact factor: 7.914
Authors: J B Fiebach; P D Schellinger; O Jansen; M Meyer; P Wilde; J Bender; P Schramm; E Jüttler; J Oehler; M Hartmann; S Hähnel; M Knauth; W Hacke; K Sartor Journal: Stroke Date: 2002-09 Impact factor: 7.914
Authors: Andria L Ford; Jennifer A Williams; Mary Spencer; Craig McCammon; Naim Khoury; Tomoko R Sampson; Peter Panagos; Jin-Moo Lee Journal: Stroke Date: 2012-11-08 Impact factor: 7.914
Authors: David T Winkler; Felix Fluri; Peter Fuhr; Stephan G Wetzel; Philippe A Lyrer; Stephan Ruegg; Stefan T Engelter Journal: Stroke Date: 2009-01-22 Impact factor: 7.914
Authors: Jonathan Emberson; Kennedy R Lees; Patrick Lyden; Lisa Blackwell; Gregory Albers; Erich Bluhmki; Thomas Brott; Geoff Cohen; Stephen Davis; Geoffrey Donnan; James Grotta; George Howard; Markku Kaste; Masatoshi Koga; Ruediger von Kummer; Maarten Lansberg; Richard I Lindley; Gordon Murray; Jean Marc Olivot; Mark Parsons; Barbara Tilley; Danilo Toni; Kazunori Toyoda; Nils Wahlgren; Joanna Wardlaw; William Whiteley; Gregory J del Zoppo; Colin Baigent; Peter Sandercock; Werner Hacke Journal: Lancet Date: 2014-08-05 Impact factor: 79.321
Authors: Ahmed A Khalil; Kersten Villringer; Vivien Filleböck; Jiun-Yiing Hu; Andrea Rocco; Jochen B Fiebach; Arno Villringer Journal: J Cereb Blood Flow Metab Date: 2018-10-18 Impact factor: 6.200
Authors: David C Lauzier; Maria M Galardi; Kristin P Guilliams; Manu S Goyal; Catherine Amlie-Lefond; Danial K Hallam; Akash P Kansagra Journal: Stroke Date: 2021-03-11 Impact factor: 7.914
Authors: Urs Fischer; Mattia Branca; Leo H Bonati; Emmanuel Carrera; Maria I Vargas; Alexandra Platon; Zsolt Kulcsar; Susanne Wegener; Andreas Luft; David J Seiffge; Marcel Arnold; Patrik Michel; Davide Strambo; Vincent Dunet; Gian Marco De Marchis; Ludwig Schelosky; Gustav Andreisek; Filip Barinka; Nils Peters; Loraine Fisch; Krassen Nedeltchev; Carlo W Cereda; Georg Kägi; Manuel Bolognese; Stephan Salmen; Rolf Sturzenegger; Friedrich Medlin; Christian Berger; Susanne Renaud; Christophe Bonvin; Michael Schaerer; Marie-Luise Mono; Biljana Rodic; Marios Psychogios; Pasquale Mordasini; Jan Gralla; Johannes Kaesmacher; Thomas R Meinel Journal: Ann Neurol Date: 2022-06-10 Impact factor: 11.274
Authors: Amie W Hsia; Marie L Luby; Richard Leigh; John K Lynch; Zurab Nadareishvili; Richard T Benson; Chandni Kalaria; Shannon P Burton; Larry Latour Journal: Neurology Date: 2021-01-20 Impact factor: 9.910